Prevalence of Helicobacter pylori infection and risk of upper gastrointestinal ulcer in patients with rheumatoid arthritis in Japan

Modern Rheumatology

Volumn 15, Issue 5, 2005, Pages 340-345

  Tanaka, Eiichi ^a   Singh, Gurkirpal ^b   Saito, Akira ^a   Syouji, Akira ^a   Yamada, Toru ^a   Urano, Wako ^a   Nakajima, Ayako ^a   Taniguchi, Atsuo ^a   Tomatsu, Taisuke ^a   Hara, Masako ^a   Saito, Terunobu ^c   Kamatani, Naoyuki ^a   Yamanaka, Hisashi ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Tokyo Hokubu Hospital   (Japan)

Author keywords

Helicobacter pylori; Nonsteroidal anti inflammatory drug (NSAID); Rheumatoid arthritis (RA); Upper gastrointestinal (UGI) ulcer

Indexed keywords

ANTIULCER AGENT; BACTERIUM ANTIBODY; DISEASE MODIFYING ANTIRHEUMATIC DRUG; HISTAMINE H2 RECEPTOR ANTAGONIST; METHOTREXATE; MISOPROSTOL; NONSTEROID ANTIINFLAMMATORY AGENT; PROTON PUMP INHIBITOR; STEROID;

ADULT; AGE; ANTIBODY TITER; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DIGESTIVE SYSTEM ULCER; FEMALE; GENDER; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; INCIDENCE; JAPAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; RISK ASSESSMENT; RISK FACTOR; SELF REPORT; SERODIAGNOSIS;

EID: 27744520392     PISSN: 14397595     EISSN: 14397609     Source Type: Journal    
DOI: 10.1007/s10165-005-0419-5     Document Type: Article

References (38)

1. BJ Marshall 1994 Helicobacter pylori Am J Gastroenterol 89 S116-28 8048402
2. S Suerbaum P Michetti 2002 Helicobacter pylori infection N Engl J Med 347 1175-86 10.1056/NEJMra020542 12374879
3. JJ Ofman CH MacLean WL Straus SC Morton ML Berger EA Roth 2002 A metaanalysis of severe upper gastrointestinal complications of nonsteroidal anti-inflammatory drugs J Rheumatol 29 804-12 11950025
4. MM Wolfe DR Lichtenstein G Singh 1999 Gastrointestinal toxicity of nonsteroidal anti-inflammatory drugs N Engl J Med 340 1888-99 10.1056/ NEJM199906173402407 10369853
5. SE Gabriel L Jaakkimainen C Bombardier 1991 Risk for serious gastrointestinal complications related to use of nonsteroidal anti-inflammatory drugs. A meta-analysis Ann Intern Med 115 787-96 1834002
6. M Asaka 1999 editor Gastric cancer: Helicobacter pylori and gastroduodenal diseases (in Japanese) Sentan Igakusha Tokyo, Japan 116-26
7. M Asaka T Kimura M Kudo H Takeda S Mitani T Miyazaki 1992 Relationship of Helicobacter pylori to serum pepsinogens in an asymptomatic Japanese population Gastroenterology 102 760-6 1537513
8. Y Shiokawa M Nobunaga T Saito S Asaki N Ogawa 1991 Epidemiology study on upper gastrointestinal lesions induced by non-steroidal anti-inflammatory drugs (in Japanese) Ryumachi 31 96-111 1858000
9. JQ Huang S Sridhar RH Hunt 2002 Role of Helicobacter pylori infection and non-steroidal anti-inflammatory drugs in peptic-ulcer disease: A meta-analysis Lancet 359 14-22 10.1016/S0140-6736(02)07273-2 11809181
10. Y Matsuda G Singh H Yamanaka E Tanaka W Urano A Taniguchi 2003 Validation of a Japanese version of the Stanford Health Assessment Questionnaire in 3763 patients with rheumatoid arthritis Arthritis Rheum 49 784-8 10.1002/art.11465 14673964
11. FC Arnett SM Edworthy DA Bloch DJ McShane JF Fries NS Cooper 1988 The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis Arthritis Rheum 31 315-24 3358796
12. T Kawai K Kawakami T Kudo S Ogiahara Y Handa F Moriyasu 2002 A new serum antibody test kit (E plate) for evaluation of Helicobacter pylori eradication Intern Med 41 780-3 12412995
13. T Fujioka M Tokieda 2000 Validity of serum anti- Helicobacter pylori antibody using enzyme immunoassay for the diagnosis in eradication of Helicobacter pylori (in Japanese) Jpn J Med Pharm Sci 43 573-9
14. H Miwa S Kikuchi K Ohtaka O Kobayashi A Ogihara M Hojo 2000 Insufficient diagnostic accuracy of imported serological kits for Helicobacter pylori infection in Japanese population Diagn Microbiol Infect Dis 36 95-9 10.1016/S0732-8893(99)00143-1 10705050
15. Y Ohtsuka T Shimada N Watanabe H Akiyama Y Suzuki M Ishida 1997 Analysis of the vacA gene sequences among Helicobacter pylori strains isolated from Japanese patients (abstract) Gastroenterology 112 A243
16. DY Graham DJ Evans Jr J Peacock JT Baker WH Schrier 1996 Comparison of rapid serological tests (FlexSure HP and QuickVue) with conventional ELISA for detection of Helicobacter pylori infection Am J Gastroenterol 91 942-8 8633585
17. B Khanna A Cutler NR Israel M Perry A Lastovica PI Fields 1998 Use caution with serologic testing for Helicobacter pylori infection in children J Infect Dis 178 460-5 9697727
18. AE van Ede RF Laan HJ Blom RA De Abreu LB van de Putte 1998 Methotrexate in rheumatoid arthritis: An update with focus on mechanisms involved in toxicity Semin Arthritis Rheum 27 277-92 10.1016/S0049-0172(98)80049-8 9572710
19. TR Cupps TL Gerrard RJ Falkoff G Whalen AS Fauci 1985 Effects of in vitro corticosteroids on B cell activation, proliferation, and differentiation J Clin Invest 75 754-61 3871795
20. M Caselli P Pazzi R LaCorte A Aleotti L Trevisani G Stabellini 1989 Campylobacter-like organisms, nonsteroidal anti-inflammatory drugs and gastric lesions in patients with rheumatoid arthritis Digestion 44 101-4 2612748
21. AS Taha I Nakshabendi FD Lee RD Sturrock RI Russell 1992 Chemical gastritis and Helicobacter pylori related gastritis in patients receiving non-steroidal anti-inflammatory drugs: Comparison and correlation with peptic ulceration J Clin Pathol 45 135-9 1541693
22. L Laine M Marin-Sorensen WM Weinstein 1992 Nonsteroidal anti-inflammatory drug-associated gastric ulcers do not require Helicobacter pylori for their development Am J Gastroenterol 87 1398-402 1415094
23. N Hudson M Balsitis F Filipowicz CJ Hawkey 1993 Effect of Helicobacter pylori colonisation on gastric mucosal eicosanoid synthesis in patients taking non-steroidal anti-inflammatory drugs Gut 34 748-51 8314505
24. Y Mizokami K Tamura Y Fukuda I Yamamoto T Shimoyama 1994 Non-steroidal anti-inflammatory drugs associated with gastroduodenal injury and Helicobacter pylori Eur J Gastroenterol Hepatol 6 suppl 1 S109-12 7735925
25. G Singh D Rosen Ramey 1998 NSAID induced gastrointestinal complications: the ARAMIS perspective - 1997. Arthritis, rheumatism, and aging medical information system J Rheumatol 51 suppl 8-16 9596549
26. CJ Hawkey 1999 COX-2 inhibitors Lancet 353 307-14 10.1016/ S0140-6736(98)12154-2 9929039
27. LS Simon AL Weaver DY Graham AJ Kivitz PE Lipsky RC Hubbard 1999 Anti-inflammatory and upper gastrointestinal effects of celecoxib in rheumatoid arthritis: A randomized controlled trial JAMA 282 1921-8 10.1001/jama.282.20.1921 10580457
28. F Wolfe J Anderson TA Burke LM Arguelles D Pettitt 2002 Gastroprotective therapy and risk of gastrointestinal ulcers: Risk reduction by COX-2 therapy J Rheumatol 29 467-73 11908558
29. P Ekstrom L Carling S Wetterhus PE Wingren O Anker-Hansen G Lundegardh 1996 Prevention of peptic ulcer and dyspeptic symptoms with omeprazole in patients receiving continuous non-steroidal anti-inflammatory drug therapy. A Nordic multicentre study Scand J Gastroenterol 31 753-8 8858742
30. ND Yeomans Z Tulassay L Juhasz I Racz JM Howard CJ van Rensburg 1998 A comparison of omeprazole with ranitidine for ulcers associated with nonsteroidal anti-inflammatory drugs. Acid Suppression Trial: Ranitidine versus Omeprazole for NSAID-associated Ulcer Treatment (ASTRONAUT) Study Group N Engl J Med 338 719-26 10.1056/NEJM199803123381104 9494148
31. CJ Hawkey JA Karrasch L Szczepanski DG Walker A Barkun AJ Swannell 1998 Omeprazole compared with misoprostol for ulcers associated with nonsteroidal anti-inflammatory drugs. Omeprazole versus Misoprostol for NSAID-induced Ulcer Management (OMNIUM) Study Group N Engl J Med 338 727-34 10.1056/NEJM199803123381105 9494149
32. DY Graham NM Agrawal SH Roth 1988 Prevention of NSAID-induced gastric ulcer with misoprostol: Multicentre, double-blind, placebo-controlled trial Lancet 2 1277-80 10.1016/S0140-6736(88)92892-9 2904006
33. American College of Rheumatology Subcommittee on Rheumatoid Arthritis Guidelines 2002 Guidelines for the management of rheumatoid arthritis: 2002 Update Arthritis Rheum 46 328-46
34. A Yanagawa T Endo 2001 Retrospective 10 years large scale evaluation of gastrointestinal lesion associated with NSAIDs in 9084 patients with rheumatoid arthritis and osteoarthritis and prophylactic efficacy of teprenone against NSAIDs AGML (in Japanese) Inflamm Regener 21 149-53
35. G Singh G Triadafilopoulos 1999 Epidemiology of NSAID induced gastrointestinal complications J Rheumatol 26 suppl 18-24
36. JF Fries 1991 NSAID gastropathy: The second most deadly rheumatic disease? Epidemiology and risk appraisal J Rheumatol 28 suppl 6-10
37. FK Chan JJ Sung SC Chung KF To MY Yung VK Leung 1997 Randomised trial of eradication of Helicobacter pylori before non-steroidal anti-inflammatory drug therapy to prevent peptic ulcers Lancet 350 975-9 10.1016/S0140-6736(97)04523-6 9329511
38. CJ Hawkey Z Tulassay L Szczepanski CJ van Rensburg A Filipowicz-Sosnowska A Lanas 1998 Randomised controlled trial of Helicobacter pylori eradication in patients on non-steroidal anti-inflammatory drugs: HELP NSAIDs study. Helicobacter Eradication for Lesion Prevention Lancet 352 1016-21 10.1016/S0140-6736(98)04206-8 9759744